Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein–nucleic acid interactions refer to the wide variety of physical and chemical contacts made between proteins and nucleic acids (DNA and RNA) in biological systems, underpinning essential processes such as transcription, replication, repair, RNA splicing, and translation[3][4]. These interactions involve multiple physical forces, such as electrostatic interactions, hydrogen bonds, hydrophobic effects, and van der Waals forces, and can be sequence-specific or structure-specific depending on the biological context[1][3][4]. Rather than representing a discrete target, the phrase describes a molecular process or interaction class, encompassing diverse proteins such as transcription factors, polymerases, and RNA-binding proteins, each of which may themselves be drug targets or have disease relevance[3][4][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein–nucleic acid interaction.